Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Sanofi healthcare receives CDSCO approval for Qftilia therapy for haemophilia patients in India

Multinational pharmaceutical company, Sanofi Healthcare announced on Wednesday that it has received authorisation from drug regulator Central Drugs Standard Control Organisation (CDSCO) for Qfitlia, a therapy used to prevent bleeding in haemophilia patients.

According to the statement released by the company, the approval from the regulator covers adults and adolescents aged 12 years and older, and older, with or without factor VIII or IX inhibitors.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.